STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
STAT
MARCH 25, 2024
But the company’s stock price fell 32% over the past five years. Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S.
Let's personalize your content